{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:05:11Z","timestamp":1780571111861,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ticks and Tick-borne Diseases"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ttbdis.2020.101468","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T15:44:48Z","timestamp":1590248688000},"page":"101468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Severe anaplasmosis represents a treatable cause of secondary hemophagocytic lymphohistiocytosis: Two cases and review of literature"],"prefix":"10.1016","volume":"11","author":[{"given":"Joseph M.","family":"Rocco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Mallarino-Haeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"McCurry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ttbdis.2020.101468_bib0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.idc.2015.02.007","article-title":"Human granulocytic anaplasmosis","volume":"29","author":"Bakken","year":"2015","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.ttbdis.2020.101468_bib0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1086\/323811","article-title":"The serological response of patients infected with the agent of human granulocytic ehrlichiosis","volume":"34","author":"Bakken","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2020.101468_bib0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cytogfr.2014.10.001","article-title":"Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders","volume":"26","author":"Brisse","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ttbdis.2020.101468_bib0020","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/jvec.12148","article-title":"Detection of Borrelia burgdorferi and Anaplasma phagocytophilum in the black-legged tick, Ixodes scapularis, within southwestern Pennsylvania","volume":"40","author":"Brown","year":"2015","journal-title":"J. Vector Ecol."},{"key":"10.1016\/j.ttbdis.2020.101468_bib0025","series-title":"Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis \u2014 United States","first-page":"65","author":"CDC","year":"2016"},{"key":"10.1016\/j.ttbdis.2020.101468_bib0030","series-title":"National Notifiable Diseases Surveillance System, 2016 Annual Tables of Infectious Disease Data","author":"CDC","year":"2017"},{"key":"10.1016\/j.ttbdis.2020.101468_bib0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1574-695X.2011.00909.x","article-title":"The biological basis of severe outcomes in Anaplasma phagocytophilum infection","volume":"64","author":"Dumler","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.ttbdis.2020.101468_bib0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/518834","article-title":"Human granulocytic anaplasmosis and macrophage activation","volume":"45","author":"Dumler","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2020.101468_bib0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.blre.2016.05.001","article-title":"Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review","volume":"30","author":"Hayden","year":"2016","journal-title":"Blood Rev."},{"key":"10.1016\/j.ttbdis.2020.101468_bib0050","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/jme\/tjv037","article-title":"Prevalence rates of Borrelia burgdorferi (Spirochaetales: Spirochaetaceae), Anaplasma phagocytophilum (Rickettsiales: Anaplasmataceae), and Babesia microti (Piroplasmida: Babesiidae) in host-seeking Ixodes scapularis (Acari: Ixodidae) from Pennsylvania","volume":"52","author":"Hutchinson","year":"2015","journal-title":"J. Med. Entomol."},{"key":"10.1016\/j.ttbdis.2020.101468_bib0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/jgid.jgid_116_16","article-title":"Hemophagocytic lymphohistiocytosis associated with Anaplasmosis","volume":"9","author":"Johnson","year":"2017","journal-title":"J. Glob. Infect. Dis."},{"key":"10.1016\/j.ttbdis.2020.101468_bib0060","first-page":"531","article-title":"Safety profile of anakinra in the management of rheumatologic, metabolic and autoinflammatory disorders","volume":"34","author":"Lopalco","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.ttbdis.2020.101468_bib0065","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/JCM.00347-13","article-title":"Comparison of a real-time PCR method with serology and blood smear analysis for diagnosis of human anaplasmosis: importance of infection time course for optimal test utilization","volume":"51","author":"Schotthoefer","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ttbdis.2020.101468_bib0070","doi-asserted-by":"crossref","first-page":"e0179655","DOI":"10.1371\/journal.pone.0179655","article-title":"Pro-inflammatory immune responses are associated with clinical signs and symptoms of human anaplasmosis","volume":"12","author":"Schotthoefer","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ttbdis.2020.101468_bib0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.berh.2014.03.002","article-title":"Macrophage activation syndrome and cytokine-directed therapies","volume":"28","author":"Schulert","year":"2014","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.ttbdis.2020.101468_bib0080","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3389\/fimmu.2018.00710","article-title":"Anaplasma phagocytophilum-related defects in CD8, NKT, and NK lymphocyte cytotoxicity","volume":"9","author":"Scorpio","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ttbdis.2020.101468_bib0085","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jiph.2017.01.002","article-title":"Fatal human anaplasmosis associated with macrophage activation syndrome in Greece and the Public Health response","volume":"10","author":"Tsiodras","year":"2017","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.ttbdis.2020.101468_bib0090","first-page":"37","article-title":"Marked elevation of serum ferritin associated with Anaplasma phagocytophilum infection","volume":"4","author":"Walkty","year":"2019","journal-title":"Off. J. Assoc. Med. Microbiol. Infect. Dis. Canada"},{"key":"10.1016\/j.ttbdis.2020.101468_bib0095","first-page":"777","article-title":"Human Granulocytic Anaplasmosis as a Cause of Febrile Illness in Korea Since at Least 2006","volume":"96","author":"Yi","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."}],"container-title":["Ticks and Tick-borne Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877959X19304741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877959X19304741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T11:56:20Z","timestamp":1598442980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877959X19304741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1877959X19304741"],"URL":"https:\/\/doi.org\/10.1016\/j.ttbdis.2020.101468","relation":{},"ISSN":["1877-959X"],"issn-type":[{"value":"1877-959X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe anaplasmosis represents a treatable cause of secondary hemophagocytic lymphohistiocytosis: Two cases and review of literature","name":"articletitle","label":"Article Title"},{"value":"Ticks and Tick-borne Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ttbdis.2020.101468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101468"}}